A drug designed to inhibit the response of cells to testosterone would alme A. a decrease in receptor tyrosine kinase activity B. a decrease in cytosolic calcium concentration C. lower cytoplasmic levels of CAMP

Human Physiology: From Cells to Systems (MindTap Course List)
9th Edition
ISBN:9781285866932
Author:Lauralee Sherwood
Publisher:Lauralee Sherwood
Chapter4: Principles Of Neural And Hormonal Communication
Section: Chapter Questions
Problem 18RE
icon
Related questions
Question

Please explain why the others arent correct.

A drug designed to inhibit the response of cells to testosterone would almost certainly result in which of the following?
A. a decrease in receptor tyrosine kinase activity
B. a decrease in cytosolic calcium concentration
C. lower cytoplasmic levels of CAMP
D. a decrease in transcriptional activity of certain genes
Transcribed Image Text:A drug designed to inhibit the response of cells to testosterone would almost certainly result in which of the following? A. a decrease in receptor tyrosine kinase activity B. a decrease in cytosolic calcium concentration C. lower cytoplasmic levels of CAMP D. a decrease in transcriptional activity of certain genes
Expert Solution
Step 1

Biology homework question answer, step 1, image 1

trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps with 2 images

Blurred answer
Knowledge Booster
Types of communication
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Human Physiology: From Cells to Systems (MindTap …
Human Physiology: From Cells to Systems (MindTap …
Biology
ISBN:
9781285866932
Author:
Lauralee Sherwood
Publisher:
Cengage Learning
Essentials of Pharmacology for Health Professions
Essentials of Pharmacology for Health Professions
Nursing
ISBN:
9781305441620
Author:
WOODROW
Publisher:
Cengage